Date | Dividend Yield | Free Cash Flow Yield | Earnings Yield | Enterprise Value (EV) |
---|
CEO | Mr. Sujal M. Patel |
IPO Date | Aug. 7, 2020 |
Location | United States |
Headquarters | 2701 Eastlake Avenue East |
Employees | 161 |
Sector | Health Care |
Industries |
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was founded in 2016 and is headquartered in Seattle, Washington.
Past 5 years
USD 1.91
USD 4.72
USD 39.83
USD 23.30
USD 1.56
USD 0.94
USD 40.12
USD 4.24
USD 3.74
USD 5.38
USD 1.60
USD 1.35
USD 9.67
StockViz Staff
January 15, 2025
Any question? Send us an email